ML349 (ML-349) is a novel, potent, reversible, highly selective and specific acyl protein thioesterase 2 (APT-2) inhibitor with a Ki of 120 nM.

LCL521 dihydrochloride (1,3DMG-B13 dihydrochloride) is a novel and potent acid ceramidase (ACDase) inhibitor.

Tris(2,4-di-tert-butylphenyl)phosphate is a bioactive compound isolated from the leaves of Vitex negundo L with anti-inflammatory activity.

Varespladib Methyl (LY-333013; A-002; S-3013) is a novel and potent sPLA2 (secretory phospholipase A2) inhibitor with the potential for treating acute coronary syndrome (ACS).

U-73343 is a novel inhibitor of PLC (phospholipase C)-dependent processes and an analogue of U-73122.

Difluprednate is a novel and potent corticosteroid.

GSK2814338 (GSK-2814338) is a novel and potent Lp-PLA2 (Lipoprotein-associated phospholipase A2) with the potential to be used for atherosclerosis and Alzheimer’s disease.